NLRP3 and Hepatic fibrosis: By administering a specific dosage of FCD, the expression of inflammation-related genes such as NLRP3 and TNF-α was reduced to their usual levels, suggesting that FCD plays a role in impeding the conversion of stellate cells to fibroblasts and reducing liver fibrosis.